Plain-English translation of NCT06114667 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether nasal high flow—a newer breathing support method that delivers warm, humidified oxygen through nose prongs—works as well as non-invasive ventilation (a breathing mask attached to a ventilator) for treating severe COPD flare-ups in the emergency department. Both methods help your lungs remove carbon dioxide and improve your blood oxygen levels. The study will compare how quickly each treatment helps patients breathe easier and stabilize.
When COPD gets severely worse, patients need breathing support urgently, but the standard mask-based ventilation can be uncomfortable and hard to tolerate. This medication offers a gentler alternative that might be easier to use while being just as effective, potentially helping more patients get the care they need.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either nasal high flow or breathing mask support in two-hour sessions while in the emergency department. During your stay, doctors will monitor your breathing, oxygen levels, and blood gases at 2, 4, 6, and 24 hours, and check how comfortable you feel. You'll also receive standard COPD medications (inhalers, steroids, and antibiotics), and the research team will follow up with you 28 days later by phone or medical records review.
AI-generated summary from trial data · Jun 26, 2026 · Not medical advice
France